Researcher
Veerle SOMERS
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Autoimmunity, General diagnostics, Adaptive immunology, Musculo-skeletal systems, Developmental neuroscience
Affiliations
- Immunology & Infection (Department)
Member
From1 Jan 2020 → Today - Immunology & Infection (Research group)
Member
From1 Jan 2020 → Today - Biomedical Research Institute (Research institute)
Member
From11 Dec 2003 → Today - Faculty of Medicine and Life Sciences (Faculty)
Member
From16 Jan 2003 → Today - Immunology - Biochemistry (Research group)
Member
From11 Dec 2003 → 31 Dec 2019 - Physiology - Biochemistry - Immunology (Department)
Member
From1 Oct 2003 → 31 Dec 2019 - Medical Basic Sciences (Division)
Member
From16 Jan 2003 → 30 Sep 2009
Projects
1 - 10 of 48
- Francqui Chair prof. dr. SwinnenFrom1 Oct 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Novel antibody biomarkers for the prediction of response to first-line therapy in rheumatoid arthritisFrom15 Jan 2023 → 14 Jan 2024Funding: IOF - technology concept exploration
- Spinal cord injury induced autoantibodies as biomarkers for patient stratificationFrom1 Nov 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Anti-UH-RA antibody reactivity for prediction of response to first-line therapy in rheumatoid arthritis: validation in the independent CAP48 cohort.From1 Oct 2022 → 1 Dec 2023Funding: Foundations, funds and other with scientific goal
- Deep immune-phenotyping of multiple sclerosis patients using advanced spectral flow cytometryFrom1 Jan 2022 → 31 Dec 2023Funding: Foundations, funds and other with scientific goal
- The MIF-CD74 system as a driver of pro-inflammatory B cell responses following traumatic spinal cord injury (SCI).From1 Oct 2021 → TodayFunding: BOF - doctoral mandates
- Elucidating the role of double homeobox protein 4 (DUX4) in the pathology of inflammatory arthritisFrom1 Jan 2021 → 31 Dec 2021Funding: Foundations, funds and other with scientific goal
- Understanding how B cell depletion with ocrelizumab affects the immune system in the treatment of MSFrom1 Jan 2021 → 30 Jun 2023Funding: Foundations, funds and other with scientific goal
- Spinal cord injury induced autoantibodies as biomarkers for patient stratificationFrom1 Nov 2020 → 31 Oct 2022Funding: FWO Strategic Basic Research Grant
- Protective versus damaging aspects of the immune reaction in relation to clinical outcome in the Limburg COVID-19 cohortFrom15 Jun 2020 → 14 Jun 2022Funding: BOF - projects
Publications
1 - 10 of 130
- The Impact of Sample Storage on Blood Methylation: Towards Assessing Myelin Gene Methylation as a Biomarker for Progressive Multiple Sclerosis(2024)
Authors: Assia TIANE, Veerle SOMERS, Niels HELLINGS, DLA van den Hove, Tim VANMIERLO
- Alterations in the innate and adaptive immune system in a real-world cohort of multiple sclerosis patients treated with ocrelizumab(2024)
Authors: Lien BECKERS, Paulien BAETEN, Veronica POPESCU, Dries SWINNEN, Alessio CARDILLI, Ibrahim HAMAD, Bart VAN WIJMEERSCH, S.J. Tavernier, Markus KLEINEWIETFELD, Bieke BROUX, et al.
Pages: 109894 - Rapamycin rescues loss of function in blood-brain barrier–interacting Tregs(2024)
Authors: Paulien BAETEN, Ibrahim HAMAD, Cindy HOEKS, Michael Hiltensperger, Bart VAN WIJMEERSCH, Veronica POPESCU, Lilian Aly, Veerle SOMERS, Thomas Korn, Markus KLEINEWIETFELD, et al.
- Novel maternal autoantibodies in autism spectrum disorder: Implications for screening and diagnosis(2023)
Authors: Rut MAZON CABRERA, Jori LIESENBORGS, Bert BRONE, Patrick VANDORMAEL, Veerle SOMERS
- ANTIBODIES OF THE IMMUNOGLOBULIN G AND A ISOTYPE TO NOVEL PEPTIDES IN EARLY AXIAL SPONDYLOARTHRITIS PATIENTS(2023)
Authors: Pieter RUYTINX, Patrick VANDORMAEL, Dana QUADEN, Elien LUYTEN, P. Geusens, Johan VANHOOF, Anouk AGTEN, Frank VANDENABEELE, K. De Vlam, Veerle SOMERS
Pages: 1225 - Comprehensive antibody and cytokine profiling in hospitalized COVID-19 patients in relation to clinical outcomes in a large Belgian cohort(2023)
Authors: Pieter RUYTINX, Patrick VANDORMAEL, Judith FRAUSSEN, Zoe PIETERS, Stef Thonissen, Niels HELLINGS, Piet STINISSEN, Ina CALLEBAUT, Joris PENDERS, Karolien VANHOVE, et al.
- IgD−CD27− double negative (DN) B cells: Origins and functions in health and disease(2023)
Authors: Lien BECKERS, Veerle SOMERS, Judith FRAUSSEN
Pages: 67 - 76 - Antibodies of the immunoglobulin a isotype to novel antigens in early axial spondyloarthritis(2023)
Authors: Pieter RUYTINX, Patrick VANDORMAEL, Dana QUADEN, Elien LUYTEN, Piet GEUSENS, Johan VANHOOF, Anouk AGTEN, Frank VANDENABEELE, Kurt de Vlam, Veerle SOMERS
- ANTIBODIES TO TWO NOVEL PEPTIDES IN NEW ONSET AXIAL SPONDYLOARTHRITIS(2022)
Authors: Pieter RUYTINX, P. Vandormael, Elien LUYTEN, A. S. De Craemer, F. Van den Bosch, D. Elewaut, Veerle SOMERS
Pages: 799 - Editorial: New Insights Into B Cell Subsets in Health and Disease(2022)
Authors: Veerle SOMERS, Deborah K. Dunn-Walters, Mirjam van der Burg, Judith FRAUSSEN
Patents
1 - 9 of 9
- Method and means for diagnosis of spondyloarthritis (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- MEANS AND METHODS FOR THE DETERMINATION OF THE JOINT DESTRUCTION PROGRESSION RATE IN RHEUMATOID ARTHRITIS PATIENTS (Inventor)
- BIOMARKERS FOR MULTIPLE SCLEROSIS (Inventor)
- CITRULLINATION SPECIFIC PHAGE DISPLAY (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- CITRULLINATION SPECIFIC PHAGE DISPLAY (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- BIOMARKERS FOR RHEUMATOID ARTHRITIS (Inventor)
Linked dataset
1 - 1 of 1